NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that the first patient has been dosed in the pivotal Phase 3 Aspire study ( NCT06617429 ...
Professor Se-Bum Paik's research team in the KAIST Department of Brain Cognitive Sciences solves the weight transport problem in artificial neural network learning by imitating random neural activity ...